• 2022-10-02
    Last Updated
  • 200
    Pages

Crohn Disease Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

marketreports.info delivers well-researched industry-wide information on the Crohn Disease market. It provides information on the market’s essential aspects such as top participants, factors driving Crohn Disease market growth, precise estimation of the Crohn Disease market size, upcoming trends, changes in consumer behavioral pattern, market’s competitive landscape, key market vendors, and other market features to gain an in-depth analysis of the Crohn Disease market. Additionally, the report is a compilation of both qualitative and quantitative assessment by industry experts, as well as industry participants across the value chain. The Crohn Disease report also focuses on the latest developments that can enhance the performance of various market segments.

This Crohn Disease report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Crohn Disease market. The Crohn Disease report presents a broad assessment of the market and contains solicitous insights, historical data, and statistically supported and industry-validated market data. The Crohn Disease report offers market projections with the help of appropriate assumptions and methodologies. The Crohn Disease research report provides information as per the market segments such as geographies, products, technologies, applications, and industries.

Key vendors engaged in the Crohn Disease market and covered in this report: AbbVie (United States), Janssen Biotech(United States), Sanofi (France), Takeda Pharmaceuticals (Japan), UCB (Belgium), Bayer AG (Germany), Bristol-Myers Squibb (United States), Eli Lilly and Co. (United States), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc (United Kingdom), Pfizer Inc. (United States), Boehringer Ingelheim GmbH (Germany), Amgen (United States), Tillotts Pharma (Switzerland)

By Application
Achieving remission (the absence of symptoms)
Maintaining remission (prevention of flare-ups)
Pediatric Disease
By Drug Type
Anti-inflammatory drugs
Immune system suppressors
Antibiotics
Biologics
Anti-diarrheal
Pain relievers

By Patterns of involvement
Jejunoileitis
Ileitis
Ileocolitis
Colitis

By Treatement
Anti-inflammatory drugs
Medications
Immunomodulators
Antibiotics
Biologic therapies

By Distribution Channel
Online
Offline

The Crohn Disease study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Crohn Disease market. Further, the report conducts an intricate examination of drivers and restraints operating in the Crohn Disease market. The Crohn Disease report also evaluates the trends observed in the parent Crohn Disease market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The Crohn Disease report also predicts the influence of different industry aspects on the Crohn Disease market segments and regions.

Researchers also carry out a comprehensive analysis of the recent regulatory changes and their impact on the competitive landscape of the Crohn Disease industry. The Crohn Disease research assesses the recent progress in the competitive landscape including collaborations, joint ventures, product launches, acquisitions, and mergers, as well as investments in the sector for research and development.

Crohn Disease Key points from Table of Content:

Scope of the study:

The research on the Crohn Disease market focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors to help clients understand their competitor’s methodologies. The Crohn Disease research also segments the Crohn Disease market on the basis of end user, product type, application, and demography for the forecast period 2022–2030. Comprehensive analysis of critical aspects such as impacting factors and competitive landscape are showcased with the help of vital resources, such as charts, tables, and infographics.

This Crohn Disease report strategically examines the micro-markets and sheds light on the impact of technology upgrades on the performance of the Crohn Disease market.

Crohn Disease Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

Major highlights of the Crohn Disease report:

  • All-inclusive evaluation of the Crohn Disease market
  • Evolution of significant Crohn Disease market aspects
  • Industry-wide investigation of Crohn Disease market segments
  • Assessment of Crohn Disease market value and volume in past, present, and forecast years
  • Evaluation of Crohn Disease market share
  • Study of niche Crohn Disease industrial sectors
  • Tactical approaches of Crohn Disease market leaders
  • Lucrative strategies to help companies strengthen their position in the Crohn Disease market

Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions such as Asia, North America, and Europe.

Chapter 1 Global Crohn Disease Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Crohn Disease Market
1.4 Restraints for Crohn Disease Market
1.5 Opportunities for Crohn Disease Market
1.6 Trends for Crohn Disease Market
1.7 COVID-19 Impact Assessment on Crohn Disease Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Crohn Disease Market Overview

2.1 Global Crohn Disease Market by Product Type
2.1.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Crohn Disease Market by End User
2.2.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Crohn Disease Market by Region
2.3.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Crohn Disease Market Outlook (2013-2029)
2.4.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Crohn Disease Market Y-o-Y Growth Rate by Region
2.8.2 Global Crohn Disease Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Crohn Disease Market Y-o-Y Growth Rate by End User
2.9 Global Crohn Disease Market Share Comparison (2013-2029)
2.9.1 Global Crohn Disease Market Share by Region
2.9.2 Global Crohn Disease Market Share by Product Type
2.9.3 Global Crohn Disease Market Share by End User

Chapter 3 North America Crohn Disease Market Overview

3.1 North America Crohn Disease Market by Product Type
3.1.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Crohn Disease Market by End User
3.2.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Crohn Disease Market by Region
3.3.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Crohn Disease Market Outlook (2013-2029)
3.4.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Crohn Disease Market Y-o-Y Growth Rate by Region
3.8.2 North America Crohn Disease Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Crohn Disease Market Y-o-Y Growth Rate by End User
3.9 North America Crohn Disease Market Share Comparison (2013-2029)
3.9.1 North America Crohn Disease Market Share by Region
3.9.2 North America Crohn Disease Market Share by Product Type
3.9.3 North America Crohn Disease Market Share by End User

Chapter 4 Europe Crohn Disease Market Overview

4.1 Europe Crohn Disease Market by Product Type
4.1.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Crohn Disease Market by End User
4.2.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Crohn Disease Market by Region
4.3.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Crohn Disease Market Outlook (2013-2029)
4.4.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Crohn Disease Market Y-o-Y Growth Rate by Region
4.8.2 Europe Crohn Disease Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Crohn Disease Market Y-o-Y Growth Rate by End User
4.9 Europe Crohn Disease Market Share Comparison (2013-2029)
4.9.1 Europe Crohn Disease Market Share by Region
4.9.2 Europe Crohn Disease Market Share by Product Type
4.9.3 Europe Crohn Disease Market Share by End User

Chapter 5 Asia Pacific Crohn Disease Market Overview

5.1 Asia Pacific Crohn Disease Market by Product Type
5.1.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Crohn Disease Market by End User
5.2.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Crohn Disease Market by Region
5.3.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Crohn Disease Market Outlook (2013-2029)
5.4.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Crohn Disease Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Crohn Disease Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Crohn Disease Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Crohn Disease Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Crohn Disease Market Share by Region
5.9.2 Asia Pacific Crohn Disease Market Share by Product Type
5.9.3 Asia Pacific Crohn Disease Market Share by End User

Chapter 6 South America Crohn Disease Market Overview

6.1 South America Crohn Disease Market by Product Type
6.1.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Crohn Disease Market by End User
6.2.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Crohn Disease Market by Region
6.3.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Crohn Disease Market Outlook (2013-2029)
6.4.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Crohn Disease Market Y-o-Y Growth Rate by Region
6.8.2 South America Crohn Disease Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Crohn Disease Market Y-o-Y Growth Rate by End User
6.9 South America Crohn Disease Market Share Comparison 2013-2029
6.9.1 South America Crohn Disease Market Share by Region
6.9.2 South America Crohn Disease Market Share by Product Type
6.9.3 South America Crohn Disease Market Share by End User

Chapter 7 MEA Crohn Disease Market Overview

7.1 MEA Crohn Disease Market by Product Type
7.1.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Crohn Disease Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Crohn Disease Market by End User
7.2.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Crohn Disease Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Crohn Disease Market by Region
7.3.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Crohn Disease Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Crohn Disease Market Outlook (2013-2029)
7.4.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Crohn Disease Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Crohn Disease Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Crohn Disease Market Y-o-Y Growth Rate by Region
7.8.2 MEA Crohn Disease Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Crohn Disease Market Y-o-Y Growth Rate by End User
7.9 MEA Crohn Disease Market Share Comparison (2013-2029)
7.9.1 MEA Crohn Disease Market Share by Region
7.9.2 MEA Crohn Disease Market Share by Product Type
7.9.3 MEA Crohn Disease Market Share by End User

Chapter 8 Global Crohn Disease Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
AbbVie (United States)
Janssen Biotech(United States)
Sanofi (France)
Takeda Pharmaceuticals (Japan)
UCB (Belgium)
Bayer AG (Germany)
Bristol-Myers Squibb (United States)
Eli Lilly and Co. (United States)
F. Hoffmann-La Roche (Switzerland)
GlaxoSmithKline plc (United Kingdom)
Pfizer Inc. (United States)
Boehringer Ingelheim GmbH (Germany)
Amgen (United States)
Tillotts Pharma (Switzerland)

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800